Wedbush Securities’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-20,200
| Closed | -$1K | – | 1151 |
|
|
2022
Q4 | $1K | Hold |
20,200
| – | – | ﹤0.01% | 1057 |
|
|
2022
Q3 | $24K | Hold |
20,200
| – | – | ﹤0.01% | 1029 |
|
|
2022
Q2 | $36K | Buy |
20,200
+500
| +3% | +$891 | ﹤0.01% | 1046 |
|
|
2022
Q1 | $40K | Sell |
19,700
-150
| -0.8% | -$305 | ﹤0.01% | 1084 |
|
|
2021
Q4 | $54K | Sell |
19,850
-5,500
| -22% | -$15K | ﹤0.01% | 1154 |
|
|
2021
Q3 | $113K | Buy |
25,350
+1,800
| +8% | +$8.02K | 0.01% | 1125 |
|
|
2021
Q2 | $137K | Buy |
23,550
+3,900
| +20% | +$22.7K | 0.01% | 1107 |
|
|
2021
Q1 | $138K | Buy |
19,650
+1,900
| +11% | +$13.3K | 0.01% | 1029 |
|
|
2020
Q4 | $85K | Buy |
17,750
+1,800
| +11% | +$8.62K | 0.01% | 842 |
|
|
2020
Q3 | $93K | Buy |
15,950
+3,000
| +23% | +$17.5K | 0.01% | 835 |
|
|
2020
Q2 | $87K | Buy |
+12,950
| New | +$87K | 0.01% | 868 |
|